Literature DB >> 1404677

Long-term results of compression treatment for lymphedema.

C J Pappas1, T F O'Donnell.   

Abstract

Although numerous operations have been devised for lymphedema, most surgeons manage this vexing condition by nonsurgical means. Previous studies by us showed that high-pressure (90 to 100 torr) sequential external pneumatic compression (SEP) reduced both limb girth and volume in a lymphedematous extremity. To assess the long-term effects of a program entailing (1) SEP, (2) elastic compression stockings to maintain the post-SEP girth, and (3) daily skin care, we reviewed the long-term courses of 49 patients managed by one surgeon. Limb girths measured at nine levels on the limb were obtained serially in follow-up (mean 25 months) by an independent observer to provide an objective response to therapy. The relative reduction in lymphedematous tissue was determined by the difference between the pretreatment, postacute treatment, and long-term treatment girths at nine points in the limb. In long-term follow-up, 26 of the patients maintained a full response (reduction at > 3 levels), whereas 10 maintained a partial response (reduction at < or = 3 levels). At late follow-up, calf and ankle girths were reduced by an absolute value of 5.37 +/- 1.01 and 4.63 +/- 0.88 cm in the full-response group and 5.43 +/- 1.58 and 3.98 +/- 1.18 cm in the partial-response group over pretreatment measurements. The degree of subcutaneous fibrosis in relationship to the duration of the edema appeared to influence results greatly. The treatment of lymphedema with SEP and compression stockings is associated with long-term maintenance of reduced limb girth in 90% of patients.

Entities:  

Mesh:

Year:  1992        PMID: 1404677     DOI: 10.1067/mva.1992.39929

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  The effectiveness of intermittent pneumatic compression in long-term therapy of lymphedema of lower limbs.

Authors:  Marzanna Zaleska; Waldemar L Olszewski; Marek Durlik
Journal:  Lymphat Res Biol       Date:  2014-06       Impact factor: 2.589

2.  Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema.

Authors:  S R Harris; M R Hugi; I A Olivotto; M Levine
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

3.  Pressures and timing of intermittent pneumatic compression devices for efficient tissue fluid and lymph flow in limbs with lymphedema.

Authors:  Marzanna Zaleska; Waldemar L Olszewski; Pradeep Jain; Sashi Gogia; Arun Rekha; Samsita Mishra; Marek Durlik
Journal:  Lymphat Res Biol       Date:  2013-12       Impact factor: 2.589

4.  Effect of pneumatic compression therapy on lymph movement in lymphedema-affected extremities, as assessed by near-infrared fluorescence lymphatic imaging.

Authors:  Melissa B Aldrich; Deborah Gross; John Rodney Morrow; Caroline E Fife; John C Rasmussen
Journal:  J Innov Opt Health Sci       Date:  2016-09-28

Review 5.  Nonoperative Treatment of Lymphedema.

Authors:  Mark V Schaverien; Julie A Moeller; Sarah D Cleveland
Journal:  Semin Plast Surg       Date:  2018-04-09       Impact factor: 2.314

6.  A newly designed SIPC device for management of lymphoedema.

Authors:  Mohammad-Hadi Saeed Modaghegh; Ehsan Soltani
Journal:  Indian J Surg       Date:  2010-02-05       Impact factor: 0.656

7.  A randomized controlled trial comparing two types of pneumatic compression for breast cancer-related lymphedema treatment in the home.

Authors:  Caroline E Fife; Suzanne Davey; Erik A Maus; Renie Guilliod; Harvey N Mayrovitz
Journal:  Support Care Cancer       Date:  2012-05-02       Impact factor: 3.603

8.  Development of a framework for pneumatic device selection for lymphedema treatment.

Authors:  Sonja M Maul; Julie A Devine; Carolyn R Wincer
Journal:  Med Devices (Auckl)       Date:  2009-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.